Wang Meiyu, Nie Jianhui, Wang Youchun
Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
Units Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic and Technology of China, Chengdu, China.
Adv Exp Med Biol. 2023;1407:133-151. doi: 10.1007/978-981-99-0113-5_7.
Seven coronaviruses have been identified that can infect humans, four of which usually cause mild symptoms, including HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1, three of which are lethal coronaviruses, named severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus 2. Pseudotyped virus is an important tool in the field of human coronavirus research because it is safe, easy to prepare, easy to detect, and highly modifiable. In addition to the application of pseudotyped viruses in the study of virus infection mechanism, vaccine, and candidate antiviral drug or antibody evaluation and screening, pseudotyped viruses can also be used as an important platform for further application in the prediction of immunogenicity and antigenicity after virus mutation, cross-species transmission prediction, screening, and preparation of vaccine strains with better broad spectrum and antigenicity. Meanwhile, as clinical trials of various types of vaccines and post-clinical studies are also being carried out one after another, the establishment of a high-throughput and fully automated detection platform based on SARS-CoV-2 pseudotyped virus to further reduce the cost of detection and manual intervention and improve the efficiency of large-scale detection is also a demand for the development of SARS-CoV-2 pseudotyped virus.
已鉴定出七种可感染人类的冠状病毒,其中四种通常引起轻微症状,包括HCoV - 229E、HCoV - NL63、HCoV - OC43和HCoV - HKU1,另外三种是致死性冠状病毒,分别为严重急性呼吸综合征冠状病毒、中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2。假型病毒是人类冠状病毒研究领域的重要工具,因为它安全、易于制备、易于检测且高度可修饰。除了假型病毒在病毒感染机制研究、疫苗以及候选抗病毒药物或抗体评估与筛选中的应用外,假型病毒还可作为一个重要平台,进一步应用于病毒变异后免疫原性和抗原性的预测、跨物种传播预测、具有更好广谱性和抗原性的疫苗株的筛选与制备。同时,随着各类疫苗的临床试验和临床后研究也相继开展,基于严重急性呼吸综合征冠状病毒2假型病毒建立高通量且全自动的检测平台,以进一步降低检测成本和人工干预,提高大规模检测效率,也是严重急性呼吸综合征冠状病毒2假型病毒发展的需求。